The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Capricor Therapeutics, Inc(NASDAQ:CAPR) 
Capricor Therapeutics, Inc., a biotechnology company, focuses on the development of transformative cell- and exosome-based therapeutics for the treatment and prevention of a broad spectrum of diseases. The company's lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has comp...
Website: http://www.capricor.com
Founded: 2005
Full Time Employees: 16
Sector: Healthcare
Industry: Biotechnology
Capricor Therapeutics Days Payable Outstanding ttm (DPO)
Capricor Therapeutics Days Receivable Outstanding ttm (DSO)
Capricor Therapeutics Days Inventory Outstanding ttm (DIO)
Capricor Therapeutics Op Cashflow Per Share ttm
Capricor Therapeutics Free Cashflow Per Share ttm
Capricor Therapeutics Cash Per Share ttm
Capricor Therapeutics P/S ratio ttm
Capricor Therapeutics (GAAP) P/E ratio ttm
Capricor Therapeutics P/B ratio ttm
No extra charts and metrics for this ticker.